ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,625Medicare Part D Prescriptions Filled, Including Refills

Rank: 190 out of 3001

$651K Total Retail Price of All Prescriptions

Rank: 352 out of 3001

543 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 543 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 543 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 12,459 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 738 667 1 3
SIMVASTATIN 613 568 2 1
OMEPRAZOLE 483 447 3 4
LISINOPRIL 436 403 4 2
FUROSEMIDE 416 412 5 6
SERTRALINE HCL 307 294 6 20
METOPROLOL TARTRATE 283 265 7 8
CITALOPRAM HBR 276 271 8 16
JANTOVEN 274 274 9 110
HYDROCODONE-ACETAMINOPHEN 247 198 S3 10 7
AMLODIPINE BESYLATE 243 206 11 5
ATENOLOL 223 193 12 18
METFORMIN HCL 220 208 13 9
ATORVASTATIN CALCIUM 214 192 14 11
WARFARIN SODIUM 200 200 15 12
DONEPEZIL HCL 199 199 16 27
TRAMADOL HCL 173 157 17 17
POTASSIUM CHLORIDE 168 165 18 15
METOPROLOL SUCCINATE 168 164 18 19
DIGOXIN 165 165 20 65
ALENDRONATE SODIUM 160 156 21 26
HYDROCHLOROTHIAZIDE 154 146 22 10
CLOPIDOGREL 152 139 23 28
LOSARTAN POTASSIUM 152 145 23 21
GABAPENTIN 148 126 25 14
MELOXICAM 144 107 26 34
ISOSORBIDE MONONITRATE ER 138 138 27 45
PRAVASTATIN SODIUM 130 125 28 13
GLYBURIDE 123 115 R 29 62
LORAZEPAM 123 117 29 96
ZOLPIDEM TARTRATE 122 117 31 24
CYMBALTA 115 110 32 53
CARVEDILOL 112 112 33 25
NAMENDA 106 106 34 40
JANUVIA 101 71 35 54
METHYLPREDNISOLONE 98 88 36 121
PLAVIX 93 89 37 46
ALLOPURINOL 93 90 37 35
TAMSULOSIN HCL 93 91 37 29
AZITHROMYCIN 90 82 40 36
MIRTAZAPINE 80 77 41 44
LOSARTAN-HYDROCHLOROTHIAZIDE 80 71 41 49
OXYBUTYNIN CHLORIDE ER 78 66 43 79
CLONIDINE HCL 73 66 44 64
TRAZODONE HCL 72 72 45 37
SYNTHROID 71 71 46 71
CRESTOR 70 48 47 33
DOXYCYCLINE HYCLATE 70 61 47 105
FENTANYL 66 66 S2 49 76
FAMOTIDINE 66 51 49 68
ADVAIR DISKUS 63 48 51 58
FLUTICASONE PROPIONATE 63 50 51 42
CIPROFLOXACIN HCL 61 56 53 56
PREDNISONE 61 57 53 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 54 55 22
TRIAMTERENE-HCTZ 59 55 56 48
QUETIAPINE FUMARATE 56 56 57 66
SPIRONOLACTONE 56 55 57 75
GLIPIZIDE 55 51 59 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.